PEMISCOT MEMORIAL HEALTH SYSTEMS
Urology is a surgical specialty that focuses on diagnosing and treating disorders of the male and female urinary tract, as well as the male reproductive system. From non-surgical issues such as urinary tract infections and hyperplasia to surgical intervention for cancers and prostatic problems, Pemiscot Memorial Urology is here to help.
Dr. David Gubin, M.D. serves as the Pemiscot Memorial Urology specialist. He primarily practices in Memphis, TN, so at Pemiscot Memorial you can receive the highest quality care that you might receive in a larger institution right at home in the Bootheel. Dr. Gubin is board certified by the American Board of Urology. Dr. Gubin evaluates, diagnoses, provides consultation, and treats any potential medical or surgical disorders of the genitourinary system and the adrenal gland. In 2020 alone, Dr. Gubin performed over 350 surgical urology procedures at Pemiscot Memorial Hospital.
Dr. Gubin performs urologic procedures at Pemiscot Memorial including:
Surgery of the lymphatic system
Open stone surgery on kidney, ureter, and bladder
Surgery on the ureter, urethra, and penis
Surgery on the urinary bladder for benign or malignant cancer
Surgery on the prostate
Plastic or reconstructive surgery on the ureter, bladder, and genitalia
Sacral nerve stimulation for urinary control
Urologic problems can affect nearly every member of the population including men, women, children, and adults. If at any time you struggle with a urologic problem, the urology specialty at Pemiscot Memorial provides the most skilled urologic care available.
Dr. David Gubin, M.D.
Practice Location: Pemiscot Memorial Hospital, The Urology Group, P.C.
Certified by the American Board of Urology, Dr. Gubin provides urologic care at Pemiscot Memorial Hospital once a week. He attended medical school at the University of Tennessee - Memphis, where remained for his internship and residency. He specializes in medical and surgical treatments of urologic disorders and primarily practices in Memphis, TN. Dr. Gubin currently retains memberships with the American Urological Association and the American Association for Clinical Urologists.
UroLift for Benign Prostatic Hyperplasia (BPH)
UroLift is a new treatment for Benign Prostatic Hyperplasia, a condition which results in age-associated prostate enlargement that can cause difficulty when urinating by blocking and reducing the flow of urine.
Over 40% of men in their 50s and over 70% of men in their 60s have BPH. While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man’s quality of life. As the prostate enlarges, it presses on and blocks the urethra, causing bothersome urinary symptoms such as:
• Frequent need to urinate both day and night
• Weak or slow urinary stream
• A sense that you cannot completely empty your bladder
• Difficulty or delay in starting urination
• Urgent feeling of needing to urinate
• A urinary stream that stops and starts
What is the UroLift System?
The UroLift System is a minimally invasive procedure to treat an enlarged prostate. It is a proven option for patients looking for an alternative to medications or major surgery. The only leading enlarged prostate procedure that does not require heating, cutting, or destruction of prostate tissue.
What happens post-op and during recovery?
Most patients can return to work within two or three days following the UroLift procedure. The most common side effects are temporary and include painful urination, blood in the urine, pelvic pain, urinary urgency and/or the inability to control the urge. These side effects should not last longer than a few days or longer in some cases. The UroLift implant is intended to be a long-lasting solution to BPH, so there should be no need for the implants to be removed. Clinical studies have proven durability out to five years.
The UroLift Delivery Device is placed through the obstructed urethra to access the enlarged prostate.
Small UroLift Implants are permanently placed to lift and hold the enlarged prostate and increase the opening of the urethra.
The UroLift Delivery
Device is removed,
leaving an open urethra to
provide symptom relief.
Typically 4-6 implants are used per patient.